Zeon Lifesciences Ltd., a research driven, leading manufacturing partner for Nutraceutical and Herbal products for Indian and global markets has announced its partnership with OptiBiotix Health Plc., a life sciences company operating in one of the most progressive areas of biotechnological research.
Zeon has a DSIR approved R&D lab with a team of professionals who have been actively involved in research on novel molecules and formulations to cater to the latest market demands. Zeon has diversified its portfolio in Medical Nutrition and has been extensively working on delivering precision nutrition for patient care. In the year 2018, Zeon was recognised by ASSOCHAM as “Best Nutraceutical Research Company”.
Zeon has a pipeline of breakthrough products which will focus on key areas of medical nutrition like cancer care, critical care, neurological supplements, etc. These will all be clinically backed up formulations which will capture the market by its efficacy.
OptiBiotix identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits.
Their R&D approach uses pharma grade platforms targeted on the food and dietary supplement markets protected by 65 patents / 17 families, 8 strain deposits, 28+ trademarks. With an established pipeline of microbiome modulators, the OptiBiotix team works today in the prevention and management of chronic lifestyle diseases including obesity, hypercholesterolemia and lipid profiles, and diabetes.
Both the leaders have joined hands to launch Optibiotix’s Slimbiome® weight management technology in India. Zeon’s expertise to manufacture with purity and precision along with Optibiotix’s patented technology is opening new paths for the Indian obesity market. According to National family health survey India-3 (NFHS-3), thirteen percent of women (15-49 Years) and nine percent of men (15-49 Years) were overweight or obese in 2005-06. This number has increased over the past decade. Taking it as a leading concern, Zeon will now offer a solution to the 29.8million obese people of India. With the leadership of visionary Mr Suresh Garg, Zeon has again proved its strong ability to undertake and deliver novel research.